About Us
Team
Investment Focus
Laboratory Products
Laboratory Services
Contract Manufacturing
Pharma Services
Specialty Pharma
Working With Us
Portfolio
News
Contact
News
February 10, 2021
February 10, 2021
Bioventus Announces Pricing of Initial Public Offering
January 20, 2021
January 20, 2021
Nexelis acquires the GSK vaccines clinical bioanalytical laboratory located in Marburg – Germany and enters into a 5-year strategic agreement with GSK
January 15, 2021
January 15, 2021
Announcing vivitide, a New Name With Continuous Commitment to Science Based on Long Experience in the World of Peptides and Antibodies
January 5, 2021
January 5, 2021
Genezen Laboratories Receives Growth Equity Investment from Ampersand Capital Partners
December 7, 2020
December 7, 2020
Adaptas Solutions Acquires Cadence Fluidics
December 2, 2020
December 2, 2020
N2 Biomedical Appoints Eric Tobin To Chief Executive Officer
December 1, 2020
December 1, 2020
Ampersand Capital Partners Establishes Portfolio Acceleration Team
November 19, 2020
November 19, 2020
Ampersand Announced Today the $670 Million Closing of the Ampersand Continuation Fund (“AMP-CF”) with Confluent Medical Technologies as Core Asset
November 11, 2020
November 11, 2020
With new CEO on board, Germany’s Vibalogics lays out $150M for Boston viral vector site
October 21, 2020
October 21, 2020
StageBio Expands Its Global Presence With Acquisition of TPL Path Labs
1
2
3
...
13
Next page